日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Kras G12C- and G12D-driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models

在小鼠模型中,Kras G12C 和 G12D 驱动的肺癌在致癌效力、免疫原性和 Kras 抑制后的复发方面存在差异。

Huang, Hai-Cheng; Deng, Qing; Guo, Lei; Gorria, Teresa; Pecci, Federica; Yang, Daniella; Rodig, Scott; De Las Casas, Luis; Hallin, Jill; Christensen, James G; Awad, Mark M; Xu, Lin; Ricciuti, Biagio; Akbay, Esra A

Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer

MTA 协同 PRMT5 抑制剂 BMS-986504 与 KRAS 抑制剂联合使用是治疗 MTAP 缺失 KRAS 突变型胰腺癌的有效策略

Drizyte-Miller, Kristina; Engstrom, Lars D; Klomp, Jeffrey A; Stalnecker, Clint A; Stamey, Addison G; Taylor, Khalilah E; Roach, Mallory K; Robb, Ryan; Waters, Laura M; Calinisan, Andrew; Degan, Seamus; Chang, Wen-Hsuan; Helu, Xousaen M; Nguyen, David; Baldelli, Elisa; Pierobon, Mariaelena; Petricoin, Emanuel F; Briere, David M; Hallin, Jill; Christensen, James G; Bryant, Kirsten L; Cox, Adrienne D; Olson, Peter; Der, Channing J

Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibitor Treatment.

分子磁共振成像检测锌分泌失调可诊断胰腺导管腺癌及对 KRASG12D 抑制剂治疗的反应。

Clavijo Jordan Veronica, Sojoodi Mozhdeh, Moloudi Farzad, Gonzalez Pagan Patricia, Jin Manyu, Pantazopoulos Pamela, French Ethan, Eissa Ibrahim, Weigand-Whittier Jonah, Rotile Nicholas, Tavallai Mehrad, Hallin Jill, Ramsay Ian, Gale Eric M, Barrett Stephen C, El-Bardeesy Nabeel, Shroff Stuti, Qadan Motaz, Tanabe Kenneth K, Caravan Peter

Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.

KRYSTAL-1 试验中,Adagrasib 治疗非小细胞肺癌患者的共突变和转录特征的影响

Negrao Marcelo V, Paula Alvaro G, Molkentine David, Hover Laura, Nilsson Monique, Vokes Natalie, Engstrom Lars, Calinisan Andrew, Briere David M, Waters Laura, Hallin Jill, Diao Lixia, Altan Mehmet, Blumenschein George R, Skoulidis Ferdinandos, Wang Jing, Kopetz Scott E, Hong David S, Gibbons Don L, Olson Peter, Christensen James G, Heymach John V

Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer

Adagrasib (MRTX849) 在脑转移瘤中的活性:KRASG12C 突变型非小细胞肺癌患者的临床前模型和临床数据

Sabari, Joshua K; Velcheti, Vamsidhar; Shimizu, Kazuhide; Strickland, Matthew R; Heist, Rebecca S; Singh, Mohini; Nayyar, Naema; Giobbie-Hurder, Anita; Digumarthy, Subba R; Gainor, Justin F; Rajan, Anant P; Nieblas-Bedolla, Edwin; Burns, Aaron C; Hallin, Jill; Olson, Peter; Christensen, James G; Kurz, Sylvia C; Brastianos, Priscilla K; Wakimoto, Hiroaki

PF-00477736 mediates checkpoint kinase 1 signaling pathway and potentiates docetaxel-induced efficacy in xenografts

PF-00477736 介导检查点激酶 1 信号通路并增强多西他赛在异种移植中诱导的疗效

Cathy Zhang, Zhengming Yan, Cory L Painter, Qin Zhang, Enhong Chen, Maria E Arango, Kyle Kuszpit, Kenneth Zasadny, Max Hallin, Jill Hallin, Anthony Wong, Dana Buckman, Guizhen Sun, Ming Qiu, Kenna Anderes, James G Christensen